Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Stavanger – page 4

131 clinical trials in Stavanger, Norway across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Stavanger at a glance
131
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

131 trials in Stavanger

Open in trial search

Study on Dabrafenib, Trametinib, and Imatinib for Patients with Rare and Hard-to-Treat Cancers

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Dabrafenib
  • Sponsor:Oslo University Hospital HF

Pneumonia

Recruiting

Study on the Effect of Amoxicillin in Preschool Children with Pneumonia

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Amoxicillin Trihydrate
  • Sponsor:Oslo University Hospital HF

Study on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Oslo University Hospital HF

Study of azacitidine combined with low-dose venetoclax treatment for patients with acute myeloid leukemia

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Rigshospitalet

Study on Treatment Strategies for Children and Adolescents with Juvenile Idiopathic Arthritis Using Methotrexate and Drug Combination

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Adalimumab
  • Sponsor:Oslo University Hospital HF

Breast cancer

Recruiting

Study on Personalized Treatment for Hormone Receptor Positive HER2 Negative Breast Cancer Using Capivasertib, Letrozole, and Bevacizumab for Eligible Patients

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Oslo University Hospital HF

Study comparing tenecteplase and acetylsalicylic acid in patients with central retinal artery occlusion within 4.

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Oslo University Hospital HF

Study of Selinexor, Bortezomib, and Lenalidomide with Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Not Eligible for Transplant

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Odense University Hospital

A Study of FOLFIRINOX Drug Combination Before Surgery Compared to Immediate Surgery in Patients with Resectable Pancreatic Head Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Oslo University Hospital HF

Study Comparing Avatrombopag and Rituximab for Adults with Immune Thrombocytopenia Not Responding to Corticosteroids

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Avatrombopag
  • Sponsor:Ostfold Hospital Trust

Cognitive disorder+1

Recruiting

Study on Fasudil Hydrochloride for Memory Loss Prevention in Early Alzheimer's Disease Patients

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Fasudil Hydrochloride
  • Sponsor:Helse Stavanger HF

Study on Dexamfetamine for Adults with Amphetamine and Opioid Dependence Undergoing Opioid Treatment

Investigational
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Dexamfetamine Sulfate
  • Sponsor:Helse Bergen HF

Other cities in Norway

The busiest research cities in the country

All 54 cities in Norway

Clinical research in Stavanger

What the registry says about research in the country

01 Respiratory Medicine

Research focusing on respiratory tract infections and breathing disorders, including studies on chronic wet cough in children and innovative treatments for asthma prevention.

  • Antibiotic efficacy in pediatric respiratory conditions
  • Viral respiratory infections management
  • Wheezing and bronchiolitis treatments

Studies evaluating new therapeutic approaches for both acute and chronic respiratory conditions.

02 Oncology Research

Comprehensive cancer studies exploring treatments for various types including breast cancer, lung cancer, and rare cancers.

  • Targeted therapies for lung cancer
  • Precision medicine in rare cancers
  • Prostate cancer biomarker studies

Focus on personalized treatment approaches and innovative therapeutic combinations.

03 Cardiovascular Medicine

Investigations into stroke prevention and cardiovascular disease management, with emphasis on new therapeutic agents.

  • Atrial fibrillation treatments
  • Atherosclerotic disease prevention
  • Acute ischemic stroke interventions

Studies aimed at reducing cardiovascular events and improving patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.